1415130-49-2

Basic information

• Product Name: ethyl 3-(5-(3-chloro-2-(((4'-chloro-2-methyl-[1,1'-biphenyl]-4-yl)amino)methyl)-5-(trifluoromethyl)phenyl)picolinamido)propanoate
• Synonyms: ethyl 3-(5-(3-chloro-2-(((4'-chloro-2-methyl-[1,1'-biphenyl]-4-yl)amino)methyl)-5-(trifluoromethyl)phenyl)picolinamido)propanoate
• CAS NO: 1415130-49-2
• Molecular Weight: 630.494
• Mol File: 1415130-49-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: ethyl 3-(5-(3-chloro-2-(((4'-chloro-2-methyl-[1,1'-biphenyl]-4-yl)amino)methyl)-5-(trifluoromethyl)phenyl)picolinamido)propanoate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 3-(5-(3-chloro-2-(((4'-chloro-2-methyl-[1,1'-biphenyl]-4-yl)amino)methyl)-5-(trifluoromethyl)phenyl)picolinamido)propanoate(1415130-49-2)
• EPA Substance Registry System: ethyl 3-(5-(3-chloro-2-(((4'-chloro-2-methyl-[1,1'-biphenyl]-4-yl)amino)methyl)-5-(trifluoromethyl)phenyl)picolinamido)propanoate(1415130-49-2)

Safety Data

• Hazardous Substances Data: 1415130-49-2(Hazardous Substances Data)

Upstream product

• 1679-18-1 4-Chlorophenylboronic acid 
• 6933-10-4 amino-5-bromo-2-toluene 
• 175205-55-7 1-bromo-3-chloro-2-iodo-5-(trifluoromethyl)benzene 
• 109919-26-8 2-bromo-6-chloro-4-(trifluoromethyl)aniline 
• 1415130-42-5 2-bromo-6-chloro-4-(trifluoromethyl)benzonitrile 
• 1415130-43-6 2-bromo-6-chloro-4-(trifluoromethyl)benzaldehyde 
• 746603-34-9 4'-chloro-2-methyl-[1,1'-biphenyl]-4-amine 
• 1415130-47-0 ethyl 3-(5-(3-chloro-2-formyl-5-(trifluoromethyl)phenyl)picolinamido)propanoate 
• 1415129-85-9 ethyl 3-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinamido)propanoate 
• 1274070-41-5 Ethyl 3-(5-bromopicolinamido)propanoate 
• 4244-84-2 ethyl β-alaninate hydrochloride 
• 30766-11-1 5-bromoisonicotinic acid 

Downstream Products

• 1415128-11-8 3-(5-(3-chloro-2-(((4'-chloro-2-methyl-[1,1'-biphenyl]-4-yl)amino)methyl)-5-(trifluoromethyl)phenyl)picolinamido)propanoic acid 

Relevant articles and documents

PICOLINAMIDO-PROPANOIC ACID DERIVATIVES USEFUL AS GLUCAGON RECEPTOR ANTAGONISTS

The present invention is directed to picolanmido-propanoic acid derivatives, pharmaceutical compositions containing them and their use in the treatment and/or prevention of disorders and conditions ameliorated by antagonizing one or more glucagon receptors, including for example metabolic diseases such as Type II diabetes mellitus and obesity.